Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
• Clinical Studies with an Antigonadotropin-Danazol via openalex
• Comparison of different treatment modalities of endometriosis in infertile women via openalex
• Comparison of different treatment modalities of endometriosis in infertile women. via openalex
• Impact of gestrinone on the course of asymptomatic endometriosis. via openalex
• Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
• Medical Management of Endometriosis via openalex
• Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone via openalex
• The effectiveness of danazol on subsequent fertility in minimal endometriosis via openalex
• The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression via openalex
• The treatment of endometriosis with Danazol. via openalex
• The use of newer progestins in the treatment of endometriosis via openalex
• THE USE OF STILBESTROL FOR ENDOMETRIOSIS via openalex
• Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. via openalex
• Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) via openalex
• Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients via openalex
• Ultrastructural changes in endometriotic implants during the menstrual cycle. via openalex
• W2418660095 via openalex
• W170259557 via openalex
• W6607058909 via openalex
• W2090487250 via openalex
• W6716512485 via openalex
• W2014486464 via openalex
• W1514612132 via openalex
• W2408619637 via openalex
• W2410955081 via openalex

Cited by (27)

• Neuroimmunology of Endometriosis-Associated Pain and Its Psychological Aspects 2024
• Berkson’s Fallacy and Endometriosis 2004
• Medical and Surgical Therapies for Pain Associated with Endometriosis 2001
• Modern Approach to Endometriosis 1997
• Danazol versus [d-Trp6]GnRH agonist for the management of infertility due to atypical endometriosis 1996
• Pain recurrence: A quality of life issue in endometriosis 1995
• Endocrine effects of GnRH analogue with low‐dose hormone replacement therapy in women with endometriosis 1995
• Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain 1995
• The biological basis of medical treatment of endometriosis 1995
• A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis 1995
• Goserelin (Zoladex) versus danazol for endometriosis: the North American experience 1994
• Postsurgical medical treatment of advanced endometriosis: Results of a randomized clinical trial 1994
• A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis 1993
• Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis 1993
• Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study 1993
• GnRH Agonists in the Treatment of Endometriosis 1993
• Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin 1992
• Endometriosetherapie mit Enantone®-Gyn Monats-Depot 1992
• Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial 1992
• Goserelin (Zoladex ) depot in the treatment of endometriosis 1992
• Treatment of estrogen-dependent gynecological disorders with the gonadotropin releasing hormone agonist buserelin 1991
• Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat 1991
• Nafarelin versus danazol in the treatment of endometriosis 1990
• Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.gif" overflow="scroll"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mtext>D</mml:mtext><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mtext>Trp</mml:mtext></mml:mrow><mml:mn>6</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:mtext>des</mml:mtext><mml:mo>-</mml:mo><mml:mtext>Gly</mml:mtext><mml:mo>-</mml:mo><mml:msubsup><mml:mrow><mml:mtext>NH</mml:mtext></mml:mrow><mml:mn>2</mml:mn><mml:mrow><mml:mn>10</mml:mn></mml:mrow></mml:msubsup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:math>LH-RH ethylamide 1990
• Gonadotropin-releasing hormone analogs in the treatment of endometriomas 1990
• Buserelin 1990
• THE EFFECT OF DANAZOL AND THE LHRH AGONIST ANALOGUE GOSERELIN (ZOLADEX) ON THE BIOLOGICAL ACTIVITY OF LUTEINIZING HORMONE IN WOMEN WITH ENDOMETRIOSIS 1990

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:09:15.954262+00:00

unpaywall

last seen: 2026-06-02T02:00:03.124865+00:00